The same structural failures that sustain the HIV epidemic also sustain tuberculosis
At 33, the retired Constitutional Court justice thought he had, maybe, seven years left. His story traces the arc from certain death because of Aids to a chronic, manageable condition at 73. He asks what happens when the generation who fought for life finally get to grow old
Eight years of violence and displacement but the lives of the people here do not make headlines
None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab
From discontinued insulin pens to overpriced TB drugs, meet the young South African holding drug makers to account on behalf of patients
The country’s medicines regulator Sahpra says it’s on track to announce its registration decision by the end of October
According to a survey, 85% of managers reported that their clinics faced staffing shortages, though only one in five blamed these on the US President’s Emergency Plan For Aids Relief cuts
The shot, called Lenacapavir, has a 100% success rate in preventing young women from getting HIV through sex
The continent has been the testing ground for drugs, devices and diagnostics, many of which never returned in the form of benefit
Weeks later, thousands of health workers are unemployed, HIV services are collapsing and the government hasn’t filled the gap. This isn’t transition, it’s unraveling in real time
With the 12 specialised key population clinics in South Africa funded by the US government, and now shuttered, getting treatment at government clinics has been difficult, if not impossible
As government clinics take on HIV patients who were previously treated by Pepfar-funded projects, the treatment of conditions like diabetes and heart disease will come under pressure
Aid dependency in the fight against HIV/Aids is not sustainable; Africa must own its health future. With political will, nothing is impossible
Africa’s first locally made HIV treatment is more than a milestone, it’s a political, economic and moral turning point in the fight for health sovereignty
If all of its National Institutes of Health funding falls away, the country could lose 70% of its medical research capacity
The Anova Health Institute, which received the lion’s share of the US President’s Emergency Plan for Aids funding in South Africa, had its support halted in February along with dozens other nonprofits
The US withdrawal will reveal the underlying truth: African health systems have long been undermined by debt and political neglect.
It is women and girls who will suffer the most from the funding crisis caused by cuts to development aid.
A modelling study released in March gives a clue at which price the jab, lenacapavir, would be worth the health department’s while
Adolescent girls and young women are blamed and shamed for falling pregnant, which affects how they are treated, the support they get, and the health services they reive
The suspension and withdrawal of US support for people’s rights in Africa is a setback
Diseases don’t respect national borders … governments all over the world need to work together to rein them in
In December, the Global Fund and the US President’s Emergency Plan for Aids Relief committed to funding the roll-out of lenacapavir in countries they support
Sources that are unrestricted, aligned with South African law and human rights, and without political interference, must be found as an alternative to the US
The US president’s cutting of financial support has cut life-saving treatment for many in SA
A federal judge has enforced a temporary restraining order blocking Donald Trump from freezing federal grants
Such programmes still qualify for a limited waiver, which will expire towards the end of April, but only for approved activities
In his 2025 State of the Nation address the president promised improved healthcare access and infrastructure
However, restrictive policies, stigma, discrimination and financial hardship can stand in the way of girls continuing their education
The US has said who qualifies for a waiver during the Trump administration’s pause in foreign aid but it doesn’t allow for anti-HIV pills, unless for pregnant women
We need to tackle the inequality in society to overcome HIV-Aids — let’s take the rights path
A groundbreaking study published in Nature Medicine gives insight into what an HIV cure could look like during infancy